A phase 3 study to evaluate enfortumab vedotin (EV) versus...

European Urology Supplements 2019 / 03 Vol. 18; Iss. 1

A phase 3 study to evaluate enfortumab vedotin (EV) versus chemotherapy in patients with previously treated locally advanced or metastatic urothelial cancer (la/mUC): EV-301, a trial-in-progress

Petrylak, D., Rosenberg, J., Duran, I., Loriot, Y., Sonpavde, G., Wu, C., Gartner, E., Melhem-Bertrandt, A., Powles, T.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Journal:
European Urology Supplements
DOI:
10.1016/S1569-9056(19)31330-2
Date:
March, 2019
File:
PDF, 108 KB
2019
Conversion to is in progress
Conversion to is failed